Condition or disease | Intervention/treatment |
---|---|
CTS | Procedure: MNT1 |
Median nerve excursion will be assessed by ultrasonography during three positions: standard MNT1, neck flexion with MNT1, and ipsilateral rotation combined with MNT1. Both arms will be tested.
Arm will be held in abduction to 90° - 110° and external rotation to 90°, forearm supination, elbow extension and wrist and fingers extension using a custom made splint.
The standard MNT1 includes neck contralateral side flexion. Then, the researcher will move the neck passively into rotation and flexion. Passive range limit will be determined prior to testing using a goniometer and passive end feel. Movement order will be randomized using an excel random function.
Every position will be tested three times. A single researcher will do all movements passively. Nerve excursion will be measured in real time by the same ultrasonographer who is blinded to patients grouping.
Study Type : | Observational |
Estimated Enrollment : | 50 participants |
Observational Model: | Case-Control |
Time Perspective: | Cross-Sectional |
Official Title: | Effect of Neck Movements on Median Nerve Longitudinal Excursion During Neurodynamic Mobilization in Patients With Carpal Tunnel Syndrome |
Actual Study Start Date : | May 1, 2019 |
Estimated Primary Completion Date : | September 1, 2020 |
Estimated Study Completion Date : | October 1, 2020 |
Group/Cohort | Intervention/treatment |
---|---|
Carpal tunnel syndrome
Patients with CTS who fulfill the following eligibility criteria: Inclusion criteria
Exclusion criteria
|
Procedure: MNT1
Participants will in supine. Arm will be position in standard MNT1. Shoulder, elbow, wrist and fingers will be maintained in the required position using a costumed splint throughout all testing. All movements will be limited to the range where pain or other symptoms are not provoked. Passive neck flexion and rotation will be added to MNT1 and will be applied as tensioning movements at level 3. All movements will be repeated three times and an average will be calculated. Myrin goniometer will be used to assess neck flexion and rotation. The movements order will be randomized using excel random generation function. Movements will be done by a single trained therapist. The end position will be held up to 10 seconds until median nerve excursion is recorded by US. For US capturing, the transducer will be positioned perpendicularly and aligned longitudinally with the median nerve at the wrist. Assessor will be blinded to participants grouping. Other Name: Neurodynamic tension test
|
Healthy control
Asymptomatic healthy age-matched control with no symptoms or history of upper quadrant disease, dysfunction, trauma or surgery.
|
Procedure: MNT1
Participants will in supine. Arm will be position in standard MNT1. Shoulder, elbow, wrist and fingers will be maintained in the required position using a costumed splint throughout all testing. All movements will be limited to the range where pain or other symptoms are not provoked. Passive neck flexion and rotation will be added to MNT1 and will be applied as tensioning movements at level 3. All movements will be repeated three times and an average will be calculated. Myrin goniometer will be used to assess neck flexion and rotation. The movements order will be randomized using excel random generation function. Movements will be done by a single trained therapist. The end position will be held up to 10 seconds until median nerve excursion is recorded by US. For US capturing, the transducer will be positioned perpendicularly and aligned longitudinally with the median nerve at the wrist. Assessor will be blinded to participants grouping. Other Name: Neurodynamic tension test
|
Ages Eligible for Study: | 30 Years to 50 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
Exclusion Criteria:
Contact: Aliaa Rehan Youssef, PhD | +201203374379 | aliaa.rehan@gmail.com |
Egypt | |
Ain Shamas University | Recruiting |
Cairo, Egypt | |
Contact: Heba Rashed, MD +201008741578 | |
Cairo University Hospital | Not yet recruiting |
Cairo, Egypt | |
Contact: Aliaa Rehan Youssef, Phd 01203374379 aliaa.rihan@pt.cu.edu.eg |
Principal Investigator: | Aliaa Rehan Youssef, Phd | Cairo University |
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | May 25, 2019 | ||||
First Posted Date | May 31, 2019 | ||||
Last Update Posted Date | July 14, 2020 | ||||
Actual Study Start Date | May 1, 2019 | ||||
Estimated Primary Completion Date | September 1, 2020 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
|
||||
Original Primary Outcome Measures | Same as current | ||||
Change History | |||||
Current Secondary Outcome Measures | Not Provided | ||||
Original Secondary Outcome Measures | Not Provided | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | Median Nerve Excursion During Neurodynamic Mobilization | ||||
Official Title | Effect of Neck Movements on Median Nerve Longitudinal Excursion During Neurodynamic Mobilization in Patients With Carpal Tunnel Syndrome | ||||
Brief Summary | This study will compare changes in longitudinal median nerve excursion when neck flexion and ipsilateral rotation are added to the standard Median neurodynamic test1 (MNT1) position in patients with carpal tunnel syndrome (CTS) and normal controls. | ||||
Detailed Description |
Median nerve excursion will be assessed by ultrasonography during three positions: standard MNT1, neck flexion with MNT1, and ipsilateral rotation combined with MNT1. Both arms will be tested. Arm will be held in abduction to 90° - 110° and external rotation to 90°, forearm supination, elbow extension and wrist and fingers extension using a custom made splint. The standard MNT1 includes neck contralateral side flexion. Then, the researcher will move the neck passively into rotation and flexion. Passive range limit will be determined prior to testing using a goniometer and passive end feel. Movement order will be randomized using an excel random function. Every position will be tested three times. A single researcher will do all movements passively. Nerve excursion will be measured in real time by the same ultrasonographer who is blinded to patients grouping. |
||||
Study Type | Observational | ||||
Study Design | Observational Model: Case-Control Time Perspective: Cross-Sectional |
||||
Target Follow-Up Duration | Not Provided | ||||
Biospecimen | Not Provided | ||||
Sampling Method | Non-Probability Sample | ||||
Study Population | Patients will be selected from primary care clinics. | ||||
Condition | CTS | ||||
Intervention | Procedure: MNT1
Participants will in supine. Arm will be position in standard MNT1. Shoulder, elbow, wrist and fingers will be maintained in the required position using a costumed splint throughout all testing. All movements will be limited to the range where pain or other symptoms are not provoked. Passive neck flexion and rotation will be added to MNT1 and will be applied as tensioning movements at level 3. All movements will be repeated three times and an average will be calculated. Myrin goniometer will be used to assess neck flexion and rotation. The movements order will be randomized using excel random generation function. Movements will be done by a single trained therapist. The end position will be held up to 10 seconds until median nerve excursion is recorded by US. For US capturing, the transducer will be positioned perpendicularly and aligned longitudinally with the median nerve at the wrist. Assessor will be blinded to participants grouping. Other Name: Neurodynamic tension test
|
||||
Study Groups/Cohorts |
|
||||
Publications * |
|
||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Recruiting | ||||
Estimated Enrollment |
50 | ||||
Original Estimated Enrollment | Same as current | ||||
Estimated Study Completion Date | October 1, 2020 | ||||
Estimated Primary Completion Date | September 1, 2020 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria |
Inclusion Criteria:
Exclusion Criteria:
|
||||
Sex/Gender |
|
||||
Ages | 30 Years to 50 Years (Adult) | ||||
Accepts Healthy Volunteers | Yes | ||||
Contacts |
|
||||
Listed Location Countries | Egypt | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT03970408 | ||||
Other Study ID Numbers | HMahmoud | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product |
|
||||
IPD Sharing Statement |
|
||||
Responsible Party | Aliaa Rehan Youssef, Cairo University | ||||
Study Sponsor | Aliaa Rehan Youssef | ||||
Collaborators | Not Provided | ||||
Investigators |
|
||||
PRS Account | Cairo University | ||||
Verification Date | July 2020 |